Literature DB >> 19017640

Co-stimulation of the bone-related Runx2 P1 promoter in mesenchymal cells by SP1 and ETS transcription factors at polymorphic purine-rich DNA sequences (Y-repeats).

Ying Zhang1, Mohammad Q Hassan, Rong-Lin Xie, John R Hawse, Thomas C Spelsberg, Martin Montecino, Janet L Stein, Jane B Lian, Andre J van Wijnen, Gary S Stein.   

Abstract

Transcriptional control of Runx2 gene expression through two alternative promoters (P1 and P2) is critical for the execution of its function as an osteogenic cell fate determining factor. In all vertebrates examined to date, the bone related P1 promoter contains a purine-rich region (-303 to -128 bp in the rat) that separates two regulatory domains. The length of this region differs dramatically between species even within the same order. Using deletion analysis, we show that part of this purine-rich region (-200 to -128) containing a duplicated element (Y-repeat) positively regulates Runx2 P1 transcription. Electrophoretic mobility assays and chromatin immunoprecipitations reveal that Y-repeat binds at least two different classes of transcription factors related to GC box binding proteins (e.g. SP1 and SP7/Osterix) and ETS-like factors (e.g. ETS1 and ELK1). Forced expression of SP1 increases Runx2 P1 promoter activity through the Y-repeats, and small interfering RNA depletion of SP1 decreases Runx2 expression. Similarly, exogenous expression of wild type ELK1, but not a defective mutant that cannot be phosphorylated, enhances Runx2 gene expression. SP1 is most abundant in proliferating cells, and ELK1 is most abundant in postconfluent cells; during MC3T3-E1 osteoblast differentiation, both proteins are transiently co-expressed when Runx2 expression is enhanced. Taken together, our data suggest that basal Runx2 gene transcription is regulated by dynamic interactions between SP1 and ETS-like factors during progression of osteogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017640      PMCID: PMC2631976          DOI: 10.1074/jbc.M807466200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Identification and comparative analysis of a second runx3 promoter.

Authors:  D Rini; F Calabi
Journal:  Gene       Date:  2001-07-25       Impact factor: 3.688

2.  Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development.

Authors:  J Y Choi; J Pratap; A Javed; S K Zaidi; L Xing; E Balint; S Dalamangas; B Boyce; A J van Wijnen; J B Lian; J L Stein; S N Jones; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

3.  Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2.

Authors:  Daniel W Young; Mohammad Q Hassan; Xiao-Qing Yang; Mario Galindo; Amjad Javed; Sayyed K Zaidi; Paul Furcinitti; David Lapointe; Martin Montecino; Jane B Lian; Janet L Stein; Andre J van Wijnen; Gary S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

4.  1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter.

Authors:  Hicham Drissi; Arlyssa Pouliot; Christian Koolloos; Janet L Stein; Jane B Lian; Gary S Stein; André J van Wijnen
Journal:  Exp Cell Res       Date:  2002-04-01       Impact factor: 3.905

5.  The RUNX3 gene--sequence, structure and regulated expression.

Authors:  C Bangsow; N Rubins; G Glusman; Y Bernstein; V Negreanu; D Goldenberg; J Lotem; E Ben-Asher; D Lancet; D Levanon; Y Groner
Journal:  Gene       Date:  2001-11-28       Impact factor: 3.688

6.  Sp1 phosphorylation regulates apoptosis via extracellular FasL-Fas engagement.

Authors:  M M Kavurma; F S Santiago; E Bonfoco; L M Khachigian
Journal:  J Biol Chem       Date:  2000-10-26       Impact factor: 5.157

7.  Characterization of the upstream mouse Cbfa1/Runx2 promoter.

Authors:  Z S Xiao; S G Liu; T K Hinson; L D Quarles
Journal:  J Cell Biochem       Date:  2001       Impact factor: 4.429

8.  Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene.

Authors:  H Drissi; Q Luc; R Shakoori; S Chuva De Sousa Lopes; J Y Choi; A Terry; M Hu; S Jones; J C Neil; J B Lian; J L Stein; A J Van Wijnen; G S Stein
Journal:  J Cell Physiol       Date:  2000-09       Impact factor: 6.384

Review 9.  Ets transcription factors and targets in osteogenesis.

Authors:  A Raouf; A Seth
Journal:  Oncogene       Date:  2000-12-18       Impact factor: 9.867

10.  The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons.

Authors:  Ditsa Levanon; David Bettoun; Catherine Harris-Cerruti; Eilon Woolf; Varda Negreanu; Raya Eilam; Yael Bernstein; Dalia Goldenberg; Cuiying Xiao; Manfred Fliegauf; Eitan Kremer; Florian Otto; Ori Brenner; Aharon Lev-Tov; Yoram Groner
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

View more
  41 in total

1.  Mitotic Inheritance of mRNA Facilitates Translational Activation of the Osteogenic-Lineage Commitment Factor Runx2 in Progeny of Osteoblastic Cells.

Authors:  Nelson Varela; Alejandra Aranguiz; Carlos Lizama; Hugo Sepulveda; Marcelo Antonelli; Roman Thaler; Ricardo D Moreno; Martin Montecino; Gary S Stein; Andre J van Wijnen; Mario Galindo
Journal:  J Cell Physiol       Date:  2015-09-18       Impact factor: 6.384

2.  FOXO1 modulates osteoblast differentiation.

Authors:  Michelle F Siqueira; Stephen Flowers; Rupa Bhattacharya; Dan Faibish; Yugal Behl; Darrell N Kotton; Lou Gerstenfeld; Elizabeth Moran; Dana T Graves
Journal:  Bone       Date:  2011-01-28       Impact factor: 4.398

3.  Dose-dependent effects of Runx2 on bone development.

Authors:  Shiqin Zhang; Zhousheng Xiao; Junming Luo; Nan He; Josh Mahlios; L Darryl Quarles
Journal:  J Bone Miner Res       Date:  2009-11       Impact factor: 6.741

4.  A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2.

Authors:  Ying Zhang; Rong-Lin Xie; Carlo M Croce; Janet L Stein; Jane B Lian; Andre J van Wijnen; Gary S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-31       Impact factor: 11.205

5.  Genomic occupancy of HLH, AP1 and Runx2 motifs within a nuclease sensitive site of the Runx2 gene.

Authors:  Hayk Hovhannisyan; Ying Zhang; Mohammad Q Hassan; Hai Wu; Carlotta Glackin; Jane B Lian; Janet L Stein; Martin Montecino; Gary S Stein; Andre J van Wijnen
Journal:  J Cell Physiol       Date:  2013-02       Impact factor: 6.384

6.  MicroRNA-208 modulates BMP-2-stimulated mouse preosteoblast differentiation by directly targeting V-ets erythroblastosis virus E26 oncogene homolog 1.

Authors:  Tomohiro Itoh; Shu Takeda; Yukihiro Akao
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

7.  Runx2 isoform I controls a panel of proinvasive genes driving aggressiveness of papillary thyroid carcinomas.

Authors:  Valentina Sancisi; Gloria Borettini; Sally Maramotti; Moira Ragazzi; Ione Tamagnini; Davide Nicoli; Simonetta Piana; Alessia Ciarrocchi
Journal:  J Clin Endocrinol Metab       Date:  2012-07-20       Impact factor: 5.958

Review 8.  Regulation of gene expression in osteoblasts.

Authors:  Eric D Jensen; Rajaram Gopalakrishnan; Jennifer J Westendorf
Journal:  Biofactors       Date:  2010 Jan-Feb       Impact factor: 6.113

9.  Regulation of the bone-restricted IFITM-like (Bril) gene transcription by Sp and Gli family members and CpG methylation.

Authors:  Bahar Kasaai; Marie-Hélène Gaumond; Pierre Moffatt
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

10.  Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation.

Authors:  Yanqiu Liu; Agnes D Berendsen; Shidong Jia; Sutada Lotinun; Roland Baron; Napoleone Ferrara; Bjorn R Olsen
Journal:  J Clin Invest       Date:  2012-08-13       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.